What does the finding of fragments of sessile serrated adenoma (sessile serrated lesion) on a colonoscopy pathology report indicate?

What Fragments of Sessile Serrated Adenoma Mean

Finding fragments of sessile serrated adenoma (also called sessile serrated lesion or sessile serrated polyp) on your colonoscopy pathology report means a precancerous polyp was detected and removed—this type of lesion accounts for 15-30% of all colorectal cancers and requires appropriate follow-up surveillance. 1

Understanding the Lesion

Sessile serrated adenomas (SSAs/SSLs) are precancerous polyps that develop through a distinct "serrated pathway" to colorectal cancer, separate from the traditional adenoma pathway 1. Key characteristics include:

• Common occurrence: Found in 8-9% of screening colonoscopies performed by expert detectors 1
• Location: Predominantly in the proximal (right) colon, though can occur anywhere 1
• Appearance: Typically flat or sessile in shape with few or no surface blood vessels, making them harder to detect than conventional adenomas 1
• Molecular features: Most are BRAF mutated (92.7%) and show CpG island methylator phenotype (CIMP) in 94% of cases 2

Cancer Risk Assessment

The term "fragments" indicates the polyp was removed in pieces (piecemeal resection), which is common practice. The cancer risk depends critically on two factors:

1. Size of the Original Lesion

• SSLs ≥10 mm: Higher risk, warrant surveillance 3
• SSLs <10 mm without dysplasia: Lower risk, generally no surveillance needed unless meeting serrated polyposis syndrome criteria 3

2. Presence of Dysplasia

• Without dysplasia: Most SSLs fall into this category and have lower immediate risk 1
• With dysplasia: Considered more advanced in the polyp-to-cancer sequence 1, 2
• With high-grade dysplasia or carcinoma: The malignant potential of SSLs equals that of conventional adenomas (12-13%) 4

Important caveat: SSLs with dysplasia can progress rapidly to invasive carcinoma, with evidence suggesting a rapid transition to malignancy after a long dwell time as an SSL without dysplasia 2, 5.

What You Need to Know About Your Specific Case

Ask your gastroenterologist these specific questions:

1. What was the size of the polyp? (≥10 mm vs <10 mm determines surveillance)
2. Was dysplasia present? (Should be explicitly stated as "with" or "without cytologic dysplasia") 1
3. Was the resection complete? (Fragments suggest piecemeal removal)
4. What was the exact location? (Proximal vs distal colon)

Recommended Follow-Up

Based on U.S. Multi-Society Task Force and British Society of Gastroenterology guidelines:

For SSLs ≥10 mm OR any SSL with dysplasia:

• One-off surveillance colonoscopy at 3 years 3
• This applies even if the lesion was completely removed

For SSLs ≥20 mm removed piecemeal:

• Examination of resection site within 2-6 months to ensure complete removal 3
• Then proceed with 3-year surveillance

For SSLs <10 mm without dysplasia:

• No surveillance indicated unless you have multiple lesions meeting serrated polyposis syndrome criteria 3

Critical Pitfalls to Avoid

1. Pathologist variability: There is poor agreement between pathologists in differentiating hyperplastic polyps from SSLs 1. If your report seems unclear, consider requesting review by a GI pathologist.

2. Incomplete resection: Piecemeal removal (indicated by "fragments") carries risk of incomplete resection. For larger lesions, the 2-6 month follow-up examination is crucial 3.

3. Underestimating risk: SSLs are more difficult to detect than conventional adenomas and have fewer surface blood vessels, meaning they may bleed less and be missed on screening tests like FIT 1.

4. Mixed histology confusion: Sometimes SSLs can have areas that look like conventional adenomas when dysplasia is present 1, 5. Ensure your pathologist clearly distinguished the predominant lesion type.

Why This Matters for Your Long-Term Health

SSLs represent a distinct pathway accounting for up to 30% of all colorectal cancers 1, 3. Recent evidence shows that physicians with higher SSL detection rates have patients with significantly lower rates of post-colonoscopy colorectal cancer (69% risk reduction in highest vs lowest detection quartile) 6. This underscores that:

• Detection and removal of these lesions prevents cancer
• Appropriate surveillance is essential
• Quality of your colonoscopy matters—SSLs are easily missed

The good news: Your lesion was detected and removed. Following the appropriate surveillance schedule based on size and dysplasia status will substantially reduce your colorectal cancer risk.